Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Matinas BioPharma Holdings, Inc. | 1,200,000 | reported | 15 Dec 2023 | tx 7+4,087,600 |
| Cadrenal Therapeutics, Inc. | 60,000 | reported | 05 Feb 2025 | tx 1+60,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2025 | GRANT_AWARD | Cadrenal Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 15 Dec 2023 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 1,200,000 | 0.00 USD | deriv |
| 20 Dec 2022 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 625,000 | 0.00 USD | deriv |
| 14 Dec 2021 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 587,600 | 0.00 USD | deriv |
| 01 Jan 2021 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 575,000 | 0.00 USD | deriv |
| 17 Jun 2020 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 250,000 | 0.00 USD | deriv |
| 01 Jan 2020 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 500,000 | 0.00 USD | deriv |
| 25 Feb 2019 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 350,000 | 0.00 USD | deriv |